Duration of Antimuscarinic Administration for Treatment of Overactive Bladder Before Which One Can Assess Efficacy: An Analysis of Predictive Factors
Author:
Publisher
Korean Continence Society
Subject
Urology,Neurology (clinical),Neurology
Link
http://einj.org/upload/pdf/inj-19-3-171.pdf
Reference26 articles.
1. Psychometric assessment of female overactive bladder syndrome and antimuscarinics-related effects
2. Autonomic dysfunction and arterial stiffness in female overactive bladder patients and antimuscarinics related effects
3. Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome
4. Tolterodine reduces the number of urge incontinence episodes in patients with an overactive bladder
5. Ocular side-effects of tolterodine and oxybutynin, a single-blind prospective randomized trial
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The application value of H-reflex induced by electrical stimulation of the sacral nerve at the S3 foramen in stimulus parameter programming;Journal of Physics: Conference Series;2024-08-01
2. Predictors for symptom improvement in overactive bladder patients treated with imidafenacin;Journal of Inclusion Phenomena and Macrocyclic Chemistry;2024-04-05
3. Evaluation of the relationship of cholinergic metabolites in urine and urgency urinary incontinence;International Urogynecology Journal;2021-04-05
4. Efficacy of Daily Intake of Dried Cranberry 500 mg in Women with Overactive Bladder: A Randomized, Double-Blind, Placebo Controlled Study;Journal of Urology;2021-02
5. Overactive bladder symptoms recurrence after sudden versus gradual weaning of Solifenacin;African Journal of Urology;2020-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3